LICORDARI, ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 2.925
NA - Nord America 2.057
AS - Asia 1.230
SA - Sud America 400
AF - Africa 55
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.670
Nazione #
US - Stati Uniti d'America 1.976
RU - Federazione Russa 1.756
SG - Singapore 543
BR - Brasile 342
CN - Cina 258
IT - Italia 238
IE - Irlanda 218
DE - Germania 198
HK - Hong Kong 146
SE - Svezia 137
FI - Finlandia 111
VN - Vietnam 83
FR - Francia 78
IN - India 68
GB - Regno Unito 51
CA - Canada 44
AT - Austria 35
PL - Polonia 24
BD - Bangladesh 22
AR - Argentina 19
JP - Giappone 18
MX - Messico 18
NL - Olanda 17
ZA - Sudafrica 17
TR - Turchia 15
MA - Marocco 14
ES - Italia 13
IQ - Iraq 13
UZ - Uzbekistan 12
CL - Cile 10
CZ - Repubblica Ceca 10
VE - Venezuela 10
EG - Egitto 9
LT - Lituania 8
SA - Arabia Saudita 8
CO - Colombia 5
CR - Costa Rica 5
JM - Giamaica 5
KZ - Kazakistan 5
UA - Ucraina 5
CH - Svizzera 4
EC - Ecuador 4
ID - Indonesia 4
NO - Norvegia 4
PH - Filippine 4
PK - Pakistan 4
AZ - Azerbaigian 3
BE - Belgio 3
BO - Bolivia 3
DZ - Algeria 3
IL - Israele 3
LY - Libia 3
MY - Malesia 3
PA - Panama 3
TN - Tunisia 3
AL - Albania 2
AU - Australia 2
BY - Bielorussia 2
ET - Etiopia 2
GR - Grecia 2
LB - Libano 2
NP - Nepal 2
PE - Perù 2
TH - Thailandia 2
TJ - Tagikistan 2
TW - Taiwan 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BT - Bhutan 1
CI - Costa d'Avorio 1
CU - Cuba 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
NG - Nigeria 1
OM - Oman 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 6.670
Città #
Ashburn 482
Moscow 450
Singapore 290
Dallas 224
Dublin 218
San Jose 195
Munich 145
Hong Kong 140
Chandler 115
Helsinki 79
Nyköping 76
Los Angeles 74
New York 74
The Dalles 72
Beijing 58
Messina 43
São Paulo 39
Lauterbourg 29
Vienna 27
Council Bluffs 26
Frankfurt am Main 24
Buffalo 22
Ho Chi Minh City 22
Santa Clara 22
Hanoi 21
Rome 21
Princeton 19
Pune 19
Montreal 18
Orem 18
Medford 17
Tokyo 17
Chennai 15
Tianjin 15
Warsaw 15
Turku 14
Chicago 13
Guangzhou 13
London 13
Redondo Beach 12
Brasília 11
Catania 11
Nuremberg 11
Phoenix 11
Rio de Janeiro 11
Seattle 11
Stockholm 11
Tashkent 11
Amsterdam 10
Manchester 10
Atlanta 9
Denver 9
Houston 9
Lappeenranta 9
Belo Horizonte 8
Boardman 8
Des Moines 8
Hillsboro 8
Milan 8
Shanghai 8
Toronto 8
Baghdad 7
Boston 7
Brooklyn 7
Campinas 7
Curitiba 7
Johannesburg 7
New Delhi 7
San Francisco 7
Caracas 6
Dhaka 6
Düsseldorf 6
Hyderabad 6
Porto Alegre 6
Wroclaw 6
Ankara 5
Barnet 5
Bexley 5
Bologna 5
Bremen 5
Mumbai 5
Newark 5
Olomouc 5
Paris 5
Poplar 5
San José 5
Casoria 4
Da Nang 4
Espoo 4
Florence 4
Istanbul 4
Itajaí 4
Kingston 4
Mexico City 4
Miami 4
Passo Fundo 4
Pescara 4
Petrosino 4
Querétaro 4
Santa Luzia 4
Totale 3.609
Nome #
62 MYOCARDIAL WORK IN CARDIAC AMYLOIDOSIS AND HYPERTENSIVE HEART DISEASE: A PRELIMINARY REPORT 345
Analysis of multilayer strain and myocardial work in patients undergoing chemotherapy treatment: a 12 months follow-up 225
Atrial fibrillation and thrombophilia. DOAC as a valid alternative? A clinical case 224
Comparison of new myocardial work indexes and others left ventricle sistolic function parameters in ischaemic patients 222
Takotsubo syndrome: prognostic predictors 217
Bicuspid aortic valve and aortopathy: novel prognostic predictors for the identification of high-risk patients 184
Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease 182
Risk stratification and early cardiotoxicity identification: organizational advantages and clinical impact of intrahospital cardiotoxicity network 178
Ruolo dell'intervello PPI post ATP fallito nella discriminazione degli ICD 165
Electrocardiographic Patterns and Arrhythmias in Cardiac Amyloidosis: From Diagnosis to Therapeutic Management—A Narrative Review 155
Advanced echocardiographic analysis to identify cardiac toxicity after TKI exposure in patients with CML 154
Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis 153
Cardiac and Vascular Impairment in Patients with Mild Psoriasis: A Longitudinal Study 152
Prognostic value of two-dimensional strain in early ischemic heart disease: A 5-year follow-up study 151
An “ordinary” case of COVID-19 pneumonia: when symptoms hide serious complications 150
PROGNOSTIC VALUE OF TWO DIMENSIONAL STRAIN IN EARLY ISCHEMIC HEART DISEASE: A 5-YEAR FOLLOW-UP STUDY 144
Mid-basal left ventricular longitudinal dysfunction as a prognostic marker in mutated transthyretin-related cardiac amyloidosis 144
Atrial Fibrillation and QT corrected. What is the best formula to use? 143
MODULATION OF THE WNT/BETA-CATENIN PATHWAY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (BETA-MI STUDY) 143
QTC CORRECTION IN ATRIAL FIBRILLATION 140
Non-invasive assessment of myocardial work: an useful tool for predicting LV remodelling after myocardial infarction? 139
Arrhythmic risk profile in mitral valve prolapse: A systematic review and metanalysis of 1715 patients 139
Early Impairment of Right Ventricular Morphology and Function in Transthyretin-Related Cardiac Amyloidosis 130
DAPAGLIFOZIN AND PULMONARY PRESSURES IN HFREF: A NON INVASIVE ASSESSMENT 127
Clinical Applications of Myocardial Work in Echocardiography: A Comprehensive Review 121
Off-Target Effects of P2Y12 Receptor Inhibitors: Focus on Early Myocardial Fibrosis Modulation 121
Symptoms-to-emergency-call timing delay in acute coronary syndrome before and during COVID-19: independent predictors and their impact on mortality 120
Assessment of Intra and Extra-Hospital Outcome after Takotsubo Syndrome in a Single-Center Population 117
The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population 116
Cardiac Magnetic Resonance in HCM Phenocopies: From Diagnosis to Risk Stratification and Therapeutic Management 115
Anthracyclines therapy and regional myocardial damage in breast cancer patients: how, when and where? 113
Impact of COVID-19 pandemic on in-hospital outcomes for patients with acute coronary syndrome: a propensity-weighted, multicentre study 108
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide survey 107
Echocardiographic Patterns of Abnormal Septal Motion: Beyond Myocardial Ischemia 106
The High Bleeding Risk Patient with Coronary Artery Disease 106
Systemic Vascular Resistance and Myocardial Work Analysis in Hypertrophic Cardiomyopathy and Transthyretin Cardiac Amyloidosis with Preserved Left Ventricular Ejection Fraction 94
Lipomatous Hypertrophy of the Interatrial Septum: A Case Report and Insights from the Literature 93
Dark papillary muscles sign: a novel prognostic marker for cardiac magnetic resonance 93
Quality of life assessment in amyloid transthyretin (ATTR) amyloidosis 93
The Incidence and Impact of In-Hospital Bleeding in Patients with Acute Coronary Syndrome during the COVID-19 Pandemic 93
Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure 92
MVP ECG risk score predicts early occurrence of atrial fibrillation after patent foramen ovale percutaneous closure 91
SCREENING FOR ANDERSON-FABRY DISEASE IN RELATIVELY YOUNG PATIENTS WITH UNEXPLAINED CONDUCTION DISORDERS REQUIRING PACEMAKER IMPLANTATION 89
Cardiac Magnetic Resonance Imaging and Arrhythmic Risk Stratification in Cardiomyopathies 87
Low QRS voltages in cardiac Amyloidosis: clinical correlates and prognostic value 86
Circulating Biomarkers in Pulmonary Arterial Hypertension: An Update 86
Transient Left Ventricular Dysfunction from Cardiomyopathies to Myocardial Viability: When and Why Cardiac Function Recovers 78
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 69
Incidence of acute myocarditis and pericarditis during the coronavirus disease 2019 pandemic: comparison with the prepandemic period 61
RISK STRATIFICATION AND PREDICTORS OF OUTCOME IN ASYMPTOMATIC AORTIC STENOSIS: THE ROLE OF MULTIMODALITY IMAGING 56
Multimodality imaging to assess severity and outcome in asymptomatic patients with aortic stenosis: a medium-long term follow-up study 51
miRNAs, PICP, and Extent of Cardiac Damage in Patients With Fabry Disease 35
The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndrome 32
Electrocardiographic heterogeneity of patients with variant transthyretin amyloid cardiomyopathy: Genotype-phenotype correlations 24
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 21
null 14
Non-Lysosomal Glycogen Storage Cardiomyopathy with Hypertrophic Phenotype Due to PRKAG2 c.905G>A (p.Arg302Gln): Case Report and Narrative Review 5
Long-term outcomes following Sacubitril/Valsartan therapy for chronic HFrEF. Italian Real-World Multicenter Study 4
Hypertrophic Cardiomyopathy Phenocopies: Classification, Key Features, and Differential Diagnosis 2
Totale 6.805
Categoria #
all - tutte 21.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.652


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022142 0 6 11 1 3 1 8 5 8 46 1 52
2022/2023588 27 48 17 25 26 82 16 44 261 11 21 10
2023/2024340 14 35 9 33 29 102 52 17 6 13 2 28
2024/20251.363 18 27 11 104 81 82 127 204 289 84 144 192
2025/20264.300 307 175 290 295 391 870 444 597 543 237 92 59
Totale 6.805